Dr. Hui Shao, our president and chief executive officer, has over 25 years of distinguished scientific and industrial background in biotechnology and pharmaceutical fields. His experience ranges from drug discovery, business strategy and product commercialization to private and public capital markets in the United States, Europe and Asia. Dr. Shao has a proven track record of leadership, spanning drug innovation at Roche, biotech investment in the United States, and strategic alliance transactions in several jurisdictions, and more. Dr. Shao received his bachelor’s degree in chemistry from the University of Science & Technology of China in 1991, his Ph.D. degree in bioorganic chemistry from the University of California, San Diego in 1996, and an M.B.A. degree in finance and accounting from the Stern School of Business, New York University in 2003. Dr. Shao is a chartered financial analyst and AICPA holder in the State of Washington, the United States.